Belgium· BE-AMP-SAM599457-00
Olmesartan Teva 10 mg
A olmesartan medoxomil product containing olmesartan medoxomil, registered in Belgium by Teva. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Olmesartan medoxomil is registered in 15 of 19 countries.
Countries holding a registration under ATC C09CA08 (olmesartan medoxomil), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 10 of them publish a price we can compare per daily dose
Olmesartan medoxomil · ATC C09CA08
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of olmesartan medoxomil costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.33 in Italy to $0.86 in Switzerland — a ×2.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Olmesartan medoxomil · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.86
- ES Spain$0.41
- IT Italy$0.33
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Olmesartan Medoxomil
- Manufacturer
- Teva
- Country
- Belgium (BE)
- ATC code
- C09CA08
- ATC class
- Olmesartan medoxomil
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
2 priced- be_apb7736630
- be_apb4567301EUR 13.27
- be_apb4567293EUR 30.22
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
216 interactions on record for olmesartan medoxomil.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olmesartan medoxomil · interactions on record
216 records
- 7 severe
- 128 moderate
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Olmesartan medoxomil in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyCARDOLS.F. GROUP S.R.L.
- CzechiaZEOTAZentiva, k.s., Praha
- FinlandBenetorMenarini International Operations Luxembourg S.A.
- IrelandOlmesartan Krka 10 mg film-coated tabletsKRKA, d.d., Novo mesto
- FranceALTEIS 10 mg, comprimé pelliculéMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- NorwayOlmesartan Medoxomil AccordAccord Healthcare B.V.
- United StatesBenicarCosette Pharmaceuticals, Inc.
- CanadaACH-OLMESARTANACCORD HEALTHCARE INC
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Mencord, Olmeblo
- Bulgaria · Tansidor, Амлосарт
- Cyprus · Olmesartan Medoxomil Jubilant, Olmesartan Tad
- Czechia · Sarten, Zeota
- Germany · Olmecor, Olmes
- Denmark · Olmesartan Medoxomil Krka
- Estonia · Mesar, Olimestra
- Spain · Atolme, Ixia
- Finland · Olmesartan Medoxomil Krka, Olmesartan Medoxomil Stada
- France · Alteis, Olmetec
- United Kingdom (Northern Ireland) · Olmesartan, Olmesartan Glenmark Pharmaceuticals Europe
- Greece · Ipertas, Olmesartan Sandoz
- Croatia · Olimestra, Olmesartan Genericon
- Hungary · Laresin
- Ireland · Olmesartan Krka, Olmesartan Medoxomil Accord Healthcare
- Italy · Cardol, Idalman
- Lithuania · Mesar, Olimestra
- Luxembourg · Belsar, Olmesartan Eg
- Latvia · Mesar, Olimestra
- Malta · Olmesartan Aurobindo Pharma (Malta), Olmesartan Vocate
- Netherlands · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Aurobindo
- Norway · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Krka
- Poland · Olimestra, Olmesartan Lek-Am
- Portugal · Atolme, Condronac
- Romania · Olmetec, Santini
- Slovenia · Olimestra, Tensiol
- Slovakia · Tenzar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fcae7af1-b62f-440f-89ce-04d5b3a285c4 GET /v1/drugs/fcae7af1-b62f-440f-89ce-04d5b3a285c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Olmesartan Teva 10 mg",
"name_fr": "Olmesartan Teva 10 mg",
"name_nl": "Olmesartan Teva 10 mg",
"amp_code": "SAM599457-00",
"strengths": [
"10.0000",
"10.0000"
],
"pack_count": 4,
"substances": [
"Olmesartan Medoxomil"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Olmesartan Medoxomil",
"authorisation_numbers": [
"BE599457"
]
}See everything about olmesartan medoxomil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.